Brainsway wins 6th CE Mark for Deep TMS to treat chronic pain
Israel's Brainsway wins CE Mark approval to treat chronic pain with its Deep TMS neurostimulation implants, marking the 6th indication for the devices.
Brainsway wins CE Mark approval for chronic pain brain-stim implant
Israeli device maker Brainsway won CE Mark approval in the European Union for its Deep TMS neurostimulation device for treatment of chronic, or neuropathic, pain.
The new approval marks the 6th CE Mark application for the Deep TMS device, joining clinical depression, bi-polar disorder, schizophrenia (negative symptoms), Parkinson's diseases and post-traumatic stress disorder.